ArticlePloS one2010

A novel HMM-based method for detecting enriched transcription factor binding sites reveals RUNX3 as a potential target in pancreatic cancer biology.

Liron Levkovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.